News
News from us and our partners
Tags
Topics
0 results
- News
Julier Medical appoints medtech industry veteran Will Martin as President and Chief Executive Officer
- News
AFYREN announces its 2026 half-year financial results
- News
Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert
- News
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
- News
Sensorion Reports 2026 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report
- News
HighLife Raises $90+Million to start its US Pivotal Study and accelerate Commercial Expansion in Europe
- News
SEK 75 million equity round bolsters enginzyme's commercial strategy
- News
Before the breakthrough: Sofinnova's decade-long bet on HighLife
- News
Abivax Presents Business Updates and First Half 2026 Financial Results
- News
GlycoEra Appoints Andrea Matthews as Chief Business Officer to Support Next Phase of Company Growth
- News
Actithera strengthens leadership team and Board as company advances towards clinical development
- News
Bionyra Pharma announces first healthy volunteers dosed in Phase 1 study of BYN-001, a long-acting IL-25 antibody for atopic dermatitis
- News
Servier and Cure 51 launch a research partnership to uncover new therapeutic targets in glioblastoma and develop new treatments derived from long term survivors’ biology
- News
NodThera changes name to Rezera Inc. and announces Ruvonoflast Phase 3 development program
- News
ProQR announces first participant dosed in Phase 1 study of AX-0811